Empyrean Bioscience Inc. has hired an investment bank to explore its strategic options, including a possible takeout. Richard Adamany, chief executive officer of Empyrean, did not return a call. Empyrean did not disclose the name of the investment bank working on its behalf.
To read the entire story, you must be logged in.
Please log in now or register with us.
